Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012:6:205-12.
doi: 10.2147/OPTH.S27187. Epub 2012 Feb 2.

The use of amniotic membrane in trabeculectomy for the treatment of primary open-angle glaucoma: a prospective study

Affiliations

The use of amniotic membrane in trabeculectomy for the treatment of primary open-angle glaucoma: a prospective study

Panagiotis Stavrakas et al. Clin Ophthalmol. 2012.

Abstract

Background: To investigate the effectiveness of amniotic membrane transplantation (AMT) on improving the outcomes of trabeculectomy in primary open-angle glaucoma (POAG).

Methods: Fifty-nine eyes affected by primary open-angle glaucoma were enrolled in this prospective randomized study. Thirty-two eyes underwent amnion-shielded trabeculectomy (study group) and 27 eyes underwent trabeculectomy without any antimetabolites (control group). Success was defined as intraocular pressure (IOP) <21 mmHg without any medications at 24 months follow-up. The two groups were compared in terms of IOP, bleb morphology, bleb survival and risk of failure, glaucoma medications, and complications.

Results: There was no statistically significant difference in terms of postoperative IOP between the two groups and at 24 months median IOP was 15.5 mmHg for the AMT group and 16 mmHg for the control group. IOP postoperative reduction was 8 mmHg for the AMT group versus 6 mmHg for the non AMT group (P = 0.276). Two patients from the study group developed IOP >21 mmHg in contrast to seven patients from the classic trabeculectomy group. The study group had 61.0% less risk of developing IOP >21 mmHg (P = 0.203). No major complications in the AMT group were observed. AMT blebs were diffuse with mild vascularization.

Conclusion: In patients with POAG, AMT showed favorable effects on bleb survival, however data failed to provide firm evidence that AMT could be used as a routine procedure in trabeculectomy.

Keywords: amniotic membrane; glaucoma filtering bleb; primary open-angle glaucoma; trabeculectomy.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Flow chart showing the progression of patients in the study.
Figure 2
Figure 2
Plot of the intraocular pressure over time. Notes: Bars indicate IQR. There was no statistical difference between the two groups at any time during the follow-up. Abbreviations: IQR, median ± inter quartile range; IOP, intraocular pressure.
Figure 3
Figure 3
Kaplan–Meier filtration surgery survival curve.
Figure 4
Figure 4
Appearance of elevated amnion shielded trabeculectomy bleb at 1 week post-op (A). Amniotic group blebs at 1 month post-op. The blebs are diffuse, with mild vascularization (B and C).
Figure 5
Figure 5
Cystic bleb of the amniotic group at 2 weeks post-op. The bleb remained dysfunctional throughout the follow-up.

References

    1. Barton K, Budenz DL, Khaw PT, Tseng SC. Glaucoma filtration surgery using amniotic membrane transplantation. Invest Ophthalmol Vis Sci. 2001;42(8):1762–1768. - PubMed
    1. Khaw PT, Doyle JW, Sherwood MB, Grierson I, Schultz G, McGorray S. Prolonged localized tissue effects from 5-minute exposures to fluorouracil and mitomycin C. Arch Ophthalmol. 1993;111(2):263–267. - PubMed
    1. Crowston JG, Akbar AN, Constable PH, Occleston NL, Daniels JT, Khaw PT. Antimetabolite induced apoptosis in Tenon’s capsule fibroblasts. Invest Ophthalmol Vis Sci. 1998;39(2):449–454. - PubMed
    1. Chen CW. Enhanced intraocular pressure controlling effectiveness of trabeculectomy by local application of mitomycin-C. Trans Asia Pacific Acad Ophthalmol. 1983;9:172–177.
    1. Chen CW, Huang HT, Bair JS, Lee CC. Trabeculectomy with simultaneous topical application of mitomycin C in refractory glaucoma. J Ocul Pharmacol. 1990;6(3):175–182. - PubMed

LinkOut - more resources